Outreach Through Facebook: Do Patients With Atopic Dermatitis Provide Clinically Relevant Information When Recruited for Surveys on Social Media?

There has been an increasing focus on the impact on the quality of life of the patients, family members, and caregivers [2], yet performing surveys to elucidate this is often laborious, time-consuming, and expensive. Table 2 shows health care use and disease management. Significance level 5%. bChi-s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JMIR dermatology 2023-10, Vol.6, p.e45226-e45226
Hauptverfasser: Frølunde, Anne Sofie, Gren, Susanne Thiesen, Frøstrup, Anne Grete, Poulsen, Peter Bo, Vastrup, Anne Skov, Vestergaard, Christian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There has been an increasing focus on the impact on the quality of life of the patients, family members, and caregivers [2], yet performing surveys to elucidate this is often laborious, time-consuming, and expensive. Table 2 shows health care use and disease management. Significance level 5%. bChi-square goodness-of-fit test for responders’ representativeness with the Danish general population—age: χ2 goodness of fit=47.8, df=3, P < .001; gender: goodness of fit χ21=87.9, P < .001; education: goodness of fit χ21=13.8, P < .001). cBasic compulsory education includes 9th and 10th grade. dYouth education includes high school and vocational school. eHigher education includes bachelor’s, master’s, or PhD programs. fPearson chi-square test for AD severity group comparison split between higher education or not. gPearson chi-square test performed for the AD severity group whose age at diagnosis was older than 12 years. hN/A: not applicable. Mild (n=37) Moderate (n=48) Severe (n=55) All (N=140) P value (between ADa severity group comparison)b Time since last AD consultation by dermatologist (n=139), n (%) .10 Within last 6 months 13 (36) 16 (33) 32 (58) 61 (44) Within last 6-12 months 4 (11) 7 (15) 3 (6) 14 (10) Within last 1-2 years 9 (25) 9 (19) 6 (11) 24 (17) More than 2 years ago 9 (25) 14 (29) 14 (26) 37 (27) Never 0 (0) 2 (4) 0 (0) 2 (1) Do not know 1 (3) 0 (0) 0 (0) 1 (1) Use of moisturizers (n=137), n (%) .45 Daily 31 (89) 40 (83) 50 (93) 121 (88) At least once a week 2 (6) 3 (6) 3 (6) 8 (6) Less than once a week 0 (0) 1 (2) 0 (0) 1 (1) When needed 2 (6) 4 (8) 0 (0) 6 (4) Never 0 (0) 0 (0) 1 (2) 1 (1) Moisturizers are recommended by the treating physician (n=137), n (%) 31 (89) 42 (89) 49 (89) 122 (89) N/Ac TCSd group, current or ever used (N=140), n (%)e Group I 17 (46) 22 (45) 22 (40) 61 (44) .79 Group II 23 (62) 38 (79) 34 (62) 95 (68) .12 Group III or IV 30 (81) 37 (77) 54 (98) 121 (86) .004 Do not know which group 1 (3) 2 (4) 0 (0) 3 (2) .33 Frequency of current TCS use (n=136), n (%) < .001 Daily 3 (9) 8 (17) 22 (40) 33 (24) 3-5 times a week 5 (14) 16 (35) 18 (33) 39 (29) 1-2 times a week 9 (26) 11 (24) 6 (11) 26 (19) 1-3 times a month 5 (14) 6 (13) 3 (6) 14 (10) Less than once a month 13 (37) 5 (11) 6 (11) 24 (18) Periods of proactive use of TCS the last year (n=134), n (%) .05 Less than 1 month 5 (15) 11 (24) 9 (17) 25 (19) 1-6 months 5 (15) 7 (15) 6 (11) 18 (14) More than 6 months 5 (15) 12 (26) 24 (44) 41 (31) No 19 (56) 16 (35) 15 (28) 50 (37) Re
ISSN:2562-0959
2562-0959
DOI:10.2196/45226